glp-1 patient NimbleRx I How to Talk to Your Doctor About Starting Therapy Patients' Use GLP-1 Drugs for

Gastroenterology 156:10411051

In a 12-week single-blind, placebo-controlled trial involving 20 obese women with PCOS, participants were randomized to subcutaneous semaglutide 1.0 mg weekly or placebo to evaluate its effect on gastric emptying (GE) using scintigraphy

Several case reports and smaller studies suggest that GLP-1 therapy can be used safely after gallbladder removal, though individual tolerance varies

Cardiometabolic Risk Factors: Greater improvements in cardiometabolic risk factors compared to those taking a placebo

Dropping lower than that can have negative consequences including muscle wasting which can lead to protein malnutrition